This review provides an overview of midline catheters and a summary of properties that influence the determination of whether a drug is appropriate for administration via midline catheter. Question:How do you recommend that we verify blood return when administering vinCRIStine in a minibag? Bethesda, MD: American Society of Healthsystem Pharmacists; 2012:1104-5. All rights reserved. Pediatr Rep. 2012 Aug 1;4(3):e28. Your institution can use them to inform practice policies and procedures, internal quality assessment, and external quality monitoring. No current standard or scoring system exists for the . Wengstrm Y, Margulies A; European Oncology Nursing Society Task Force. 2006;12(2):113-8. The organization also recommends a multidisciplinary review of the process regarding the preparation and administration of vinCRIStine in each practice setting. 2022 Dec 2;12:1021488. doi: 10.3389/fonc.2022.1021488. Prevention is the most important approach to extravasation management. No solid research exists regarding IV chemotherapy administration setups, because they can vary greatly based on the regimen, equipment availability, and patient status. ACR Committee on Drugs and Contrast Media. Bookshelf Disclaimer. The loss of drug in the tubing exceeds the 5% dose variability acceptable for our chemotherapy doses per our hospital policy. sharing sensitive information, make sure youre on a federal When the institution implements the use of minibags to administer vinCRIStine, the following nursing guidelines should be followed to further reduce the risk of harm from extravasation. 8600 Rockville Pike 2008 Sep;12(4):357-61. Click to reveal 2012;18(suppl):16-7. The main consideration in determining whether a drug is appropriate for administration via midline catheter is its propensity for causing phlebitis.2Phlebitis is inflammation of a vein caused by damage to the tunica intima, which may be accompanied by erythema, swelling, pain, heat, and a palpable cord if thrombosis is present. 2. (K k0|hzv 6gN5UzVa+91C+yTOOcV^t^IjpiOROeutcI9GOqs'."XA*c2@GfK!rKP;{4?|h=,G _wyNdfSc#A]LHq#@Gtn[YWk%1o*Bbyk'82h6~IOvvi2`6 125 Enterprise Drive doi: 10.4081/pr.2012.e28. Since 1975, ONS has provided a professional community for oncology nurses, developed evidence-based education programs and treatment information, and advocated for patient care, all in an effort to improve the quality of life and outcomes for patients with cancer and their families.